STARTUP/TECHNOLOGY
Anupam Rasayan India First Firm Globally To Start ETFA Production
Anupam Rasayan India Ltd., a custom synthesis and specialty chemicals company, has announced the commercialisation of Ethyl Trifluoroacetate (ETFA) production through its proprietary process-by-design continuous flow chemistry platform. ETFA is a critical fluorinated building block and reagent used in the synthesis of a wide range of organic fluorine compounds. These compounds find applications across life […]
CW Bureau
·
Jun 11, 2026
GENERAL
Cipla Bets On Innovation, Biosimilars And AI To Drive Next Phase Of Growth
Cipla Ltd, the Mumbai-headquartered global pharmaceutical major, is stepping up investments in innovation, artificial intelligence, biosimilars and strategic acquisitions as it looks to strengthen its position across key global markets and build a future-ready organisation. India will remain a key growth driver, with the company focusing on therapy areas including respiratory, cardiology, diabetology, urology, oncology, […]
CW Bureau
·
Jun 2, 2026
GENERAL
After 90 Years Of ‘Caring For Life’, Cipla Charts Innovative Journey Path
Ninety years ago, Mumbai headquartered Cipla Ltd, began with a mission to make medicines affordable and accessible for Indians. What started as a commitment to self-reliance in pharmaceuticals has evolved into a global healthcare enterprise serving millions of patients across markets. As Cipla celebrates 90 years of its journey, the company is looking ahead with […]
CW Bureau
·
Jun 2, 2026
GENERAL
Sun Pharmaceuticals To Acquire Organon In $11.75-Bn All-Cash Deal
Sun Pharmaceutical Industries Ltd, leading specialty generics company, will acquire Organon at $14 per share in an all-cash transaction, valuing the company at an enterprise value of $11.75 billion, funded through internal accruals and borrowings. The transaction will be executed through a merger of Organon with a subsidiary of Sun Pharma, with Organon surviving the […]
CW Bureau
·
Apr 27, 2026
GENERAL
US Department Of Justice Drop All Charges Against Vasudha Pharma
Vasudha Pharma Chem Ltd said the U.S. Department of Justice has dropped all charges against it after finding no evidence of wrongdoing, with no outstanding criminal or civil liabilities remaining against the company. The company said it has entered into a Non-Prosecution Agreement with the DOJ on April 16, 2025 and had strengthened its compliance […]
CW Bureau
·
Apr 17, 2026
HOSPITALITY
Rubicon Research To Buy 85% Stake In Arinna Lifesciences For ₹175.92 Cr
Rubicon Research Ltd has entered into definitive agreements to acquire an 85% stake in Arinna Lifesciences Ltd for a consideration of ₹175.92 crore, marking a strategic expansion in the domestic formulations market. The transaction, which values Arinna at an enterprise value of ₹200 crore on a cash and debt-free basis, is expected to be concluded […]
CW Bureau
·
Apr 15, 2026
